These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9916624)

  • 1. The sixth quality control exercise of the Central European tissue typing laboratories.
    Fischer G; Kreuzer D; Beer U; Gleissner B; Wasilewski K; Faé I
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S14-6. PubMed ID: 9916624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quality control for HLA typing].
    Bogunia-Kubik K; Łaba A; Lange A
    Postepy Hig Med Dosw; 2000; 54(6):759-66. PubMed ID: 11227374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients.
    Baxter-Lowe LA; Keever C; Dinauer D; Daniels T; Johnson K; Camitta B; Drobyski W; Garbrecht F; Horowitz M; Pietryga D
    Transplant Proc; 1995 Feb; 27(1):1377-8. PubMed ID: 7878917
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of the HLA proficiency testing for Central and East Europe.
    Bogunia-Kubik K; Lange A
    Int J Immunogenet; 2008 Aug; 35(4-5):409-16. PubMed ID: 18976448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.
    Tiercy JM; Stadelmann S; Chapuis B; Gratwohl A; Schanz U; Seger RA; Faveri GN; Kern M; Morell A; Schwabe R; Schneider P
    Bone Marrow Transplant; 2003 Sep; 32(6):623-7. PubMed ID: 12953136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control for registry HLA data.
    Tiercy JM; Fischer G; Setterholm M
    Tissue Antigens; 2007 Apr; 69 Suppl 1():13-4. PubMed ID: 17445155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of high-resolution HLA-A, -B, -Cw, -DRB1, and -DQB1 alleles and haplotypes in 718 Chinese marrow donors based on donor-recipient confirmatory typings.
    Hei AL; Li W; Deng ZH; He J; Jin WM; Du D; Zhou XY; Xiao Y; Zhang ZX; Cai JP
    Int J Immunogenet; 2009 Oct; 36(5):275-82. PubMed ID: 19674163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serological class II typing with DNA-DR and DNA-DQ typing of kidney donors and recipients.
    Trejaut J; Dunckley H; Sullivan JS; Doran T; Chapman J
    Transplant Proc; 1990 Oct; 22(5):2133. PubMed ID: 1977223
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintaining updated DNA-based HLA assignments in the National Marrow Donor Program Bone Marrow Registry.
    Maiers M; Hurley CK; Perlee L; Fernandez-Vina M; Baisch J; Cook D; Fraser P; Heine U; Hsu S; Leffell MS; Mauer D; Noreen H; Tang T; Trucco M; Yang SY; Hartzman RJ; Setterholm M; Winden T; Shepherd D; Hegland J
    Rev Immunogenet; 2000; 2(4):449-60. PubMed ID: 12361088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR and DQ matching by DNA restriction fragment length polymorphism methods and the outcome of mixed lymphocyte reaction tests in unrelated bone marrow donor searches. The IMUST Study.
    Howard MR; Brookes P; Bidwell JL; Bidwell EA; Clay TM; Evans JL; Hows JM; Bradley BA
    Bone Marrow Transplant; 1992 Mar; 9(3):161-6. PubMed ID: 1354994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic HLA-DR and -DQ typing by Taq I RFLP analysis: an alternative to serologic tissue typing.
    Olerup O; Zetterquist H; Ohlson L; Carlsson B; Wallin J; Möller E
    Transplant Proc; 1990 Feb; 22(1):144. PubMed ID: 1968689
    [No Abstract]   [Full Text] [Related]  

  • 13. International Cell Exchange: 1992.
    Lau M; Terasaki PI; Park MS
    Clin Transpl; 1992; ():457-73. PubMed ID: 1306719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.
    Doxiadis II; Witvliet M; Verduyn W; de Lange P; Tanke J; Schreuder GM; Persijn GG; Claas FH
    Clin Transpl; 2000; ():99-103. PubMed ID: 11512364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. II. HLA-DR, DQ serologic typing, antibody identification, and B-cell crossmatching. American Society for Histocompatibility of Immunogenetics. College of American Pathologists.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 1994 Feb; 39(2):96-105. PubMed ID: 8175388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Cell Exchange, 1994.
    Lau M; Terasaki PI; Park MS
    Clin Transpl; 1994; ():467-88. PubMed ID: 7547576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRB polymerase chain reaction fingerprinting, DQA oligotyping and mixed lymphocyte culture results in related bone marrow donors and recipients.
    Brojer E; Sankowska M; Stańczak JJ; Gronkowska A; Stepień-Sopniewska B; Górski A; Zupańska B
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):89-92. PubMed ID: 8744721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population.
    Dunne C; Crowley J; Hagan R; Rooney G; Lawlor E
    Int J Immunogenet; 2008 Aug; 35(4-5):295-302. PubMed ID: 18976432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemically detected HLA-DQ polymorphism in DR-matched donors and recipients of renal allografts.
    Carter C; Fuggle SV; Ting A; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):639-40. PubMed ID: 2650208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of HLA class II PCR typing for the outcome of mixed lymphocyte reaction.
    Cukrová V; Loudová M; Srámková I; Dolezalová L; Vítek A
    Folia Biol (Praha); 1998; 44(4):137-41. PubMed ID: 10732703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.